Home > Products > CD28 & CD3
> Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (scIgG)
Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (scIgG) (CAT#: SCIGG-054)
Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD28 and anti-CD3 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can improve T-cell activation. It is designed for the research of Tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (scIgG) (SCIGG-054). Click the button below to contact us or submit your feedback about this product.